Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,368 | -20,965 | -16,454 | -12,140 | -5,771 |
| Depreciation Amortization | 65 | 1 | -4 | -8 | -9 |
| Accounts payable and accrued liabilities | -1,039 | 415 | -135 | -275 | 473 |
| Other Working Capital | -1,120 | 1,521 | 586 | 676 | 942 |
| Other Operating Activity | 1,400 | 3,725 | 4,386 | 4,293 | 990 |
| Operating Cash Flow | $-4,062 | $-15,303 | $-11,619 | $-7,456 | $-3,376 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -34,444 | -6,315 | -6,315 | -4,467 | -448 |
| Sale Of Investment | 450 | 10,208 | 4,800 | 4,350 | 4,350 |
| Investing Cash Flow | $-33,994 | $3,893 | $-1,515 | $-117 | $3,902 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 234 | 234 | 234 | N/A |
| Debt Repayment | -833 | -1,667 | -1,111 | -1,111 | -833 |
| Common Stock Issued | 30,274 | 22,332 | 17,222 | 12,559 | 5,714 |
| Financing Cash Flow | $29,440 | $20,899 | $16,344 | $11,682 | $4,880 |
| Beginning Cash Position | 24,217 | 14,729 | 14,729 | 14,729 | 14,729 |
| End Cash Position | 15,602 | 24,217 | 17,938 | 18,838 | 20,135 |
| Net Cash Flow | $-8,616 | $9,489 | $3,210 | $4,109 | $5,406 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,062 | -15,303 | -11,619 | -7,456 | -3,376 |
| Free Cash Flow | -4,062 | -15,303 | -11,619 | -7,456 | -3,376 |